138286-73-4

Upstream product

• 135036-19-0 4-phenyl-1-(phenylmethyl)-2-piperazinecarboxamide 
• 58077-34-2 N¹-benzyl-N²-phenylethane-1,2-diamine 

Downstream Products

• 135036-34-9 4-phenyl-1-(phenylmethyl)-2-piperazinemethanol 
• 135036-16-7 N-[4-[(4-Phenylpiperazin-2-yl)methoxy]phenyl]methanesulfonamide hydrochloride 
• 135036-37-2 N-<4-<<4-phenyl-1-(phenylmethyl)piperazin-2-yl>methoxy>phenyl>methanesulfonamide 
• 135036-35-0 2-<(4-nitrophenoxy)methyl>-4-phenyl-1-(phenylmethyl)piperazine 
• 135036-36-1 2-<(4-aminophenoxy)methyl>-4-phenyl-1-(phenylmethyl)piperazine 

Relevant academic research and scientific papers

Synthesis, cardiac electrophysiology, and β-blocking activity of novel arylpiperazines with potential as class II/III antiarrhythmic agents

A series of novel arylpiperazines have been prepared in an attempt to incorporate both class II (β-receptor blocking) and class III antiarrhythmic properties in a single molecule. The key step in the preparation of the new compounds involves a regioselect

2-substituted-1(4)-aryl piperazines and the process for their preparation

This invention relates to novel 2-substituted-1(4)-aryl piperazines and to a process for their preparation. The compounds of this invention have been found to have cardiovascular, primarily antiarrhythmic effects and are of the following general formula I